ArticleOncoTargets and therapy2014

Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer.

Tommaso Susini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.